Our customer service representatives are available 24 hours a day, from Monday to Sunday.

PEG-PCL Microspheres

Online Inquiry

General Information

  • Product Name: PEG-PCL Microspheres
  • CAS: PEG 25322-68-3; PCL 24980-41-4
  • Catalog: CI-MIC-005
  • Applications: Medical beauty, tissue engineering, and regenerative medicine, drug delivery

PEG-PCL microspheres are an important type of amphiphilic polymer microspheres that combine the properties of polyethylene glycol (PEG) and polycaprolactone (PCL). These microspheres have gained significant attention in biomedical applications due to their unique properties.

ItemsSpecification
Viscosity-Average Molecular Weight30,000-50,000; 70,000-90,000; 90,000-110,000 g/mol (customizable)
Molecular Weight Distribution (GPC)≤ 2.0
Particle Size20-40μm, 40-60μm
Span≤ 0.7

Key Characteristics

  • Biocompatibility: PEG provides excellent compatibility with biological tissues, minimizing immune response.
  • Biodegradability: PCL allows the microspheres to degrade naturally within the body, reducing the need for removal after completing their function.
  • Biosafety: These materials are considered safe for use in medical and pharmaceutical applications.

Applications

  • Medical Beauty: PEG-PCL microspheres are used for controlled delivery of bioactive agents, enhancing skin hydration, anti-aging effects, and rejuvenation with superior biocompatibility, stability, and prolonged release performance.
  • Tissue Engineering: In tissue engineering, PEG-PCL microspheres serve as scaffolds or carriers for cells and growth factors. Their biocompatibility and degradability make them ideal for promoting tissue regeneration and healing.
  • Regenerative Medicine: PEG-PCL microspheres are also being explored in regenerative medicine, where they help in the repair and replacement of damaged tissues. Their tunable properties allow them to be customized for specific applications, such as promoting bone, cartilage, or skin regeneration.
  • Drug Delivery: One of the most notable uses of PEG-PCL microspheres is in drug delivery. Their amphiphilic nature allows them to encapsulate both hydrophilic and hydrophobic drugs, providing controlled and sustained release, enhancing therapeutic efficacy, and reducing side effects.

Alfa Chemistry offers high-quality PEG-PCL microspheres, known for their excellent biocompatibility, biodegradability, and biosafety, ideal for applications in medical beauty, drug delivery, tissue engineering, and regenerative medicine. For more information, please feel free to contact us.

Case Study

PCL‑PEG‑PCL Porous Microspheres as Injectable Cell Carriers and Cross‑Linkers for Alginate Hydrogels in Skin Wound Healing

PCEC porous microspheres loaded with calcium gluconate cross‑link alginate improve skin wound healing.Liao, JinFeng, et al. ACS Biomaterials Science & Engineering 4.3 (2018): 1029-1036.

Poly(ε-caprolactone)-b-poly(ethylene glycol)-b-poly(ε-caprolactone) (PCL‑PEG‑PCL or PCEC) porous microspheres serve a dual function: they deposit calcium gluconate crystals within their pores to cross‑link alginate into an injectable hydrogel, and their porous structure provides anchor points for fibroblast attachment and proliferation, enhancing skin regeneration.

Fabrication and Characterization: PCEC triblock copolymer (Mn 50 kDa) was synthesized by ring‑opening polymerization. Porous microspheres (diameter ~212 µm, pore size ~8 µm) were prepared by w/o/w double emulsion using NH4HCO3 as a porogen. Calcium gluconate crystals were deposited inside the pores by sequential soaking in calcium gluconate solution and ethanol. The calcium‑loaded microspheres were mixed with alginate solution to form an injectable hydrogel that cross‑linked within 3 min.

Performance Evaluation: The hybrid hydrogel showed no cytotoxicity (cell viability ~100% at 500 µg/mL, MTT). SEM and confocal microscopy confirmed that 3T3 and L929 fibroblasts adhered to and infiltrated the porous microspheres, extending across the pores. In a rat full‑thickness skin defect model, the hydrogel‑treated group achieved 91% wound closure at day 7 (control: 75%), with greater epidermal thickness (49.7 µm vs. 23.3 µm). At day 14, treated wounds showed regenerated hair follicles, higher granulation tissue score (4.17 vs. 3.57), and denser, parallel‑arranged collagen fibers. Mild early inflammation resolved by day 14.

Conclusion: PCEC porous microspheres enable injectable, cell‑friendly alginate hydrogels that significantly accelerate wound closure and promote organized collagen deposition, making them promising for skin tissue engineering.

PCL-PEG-PCL Microspheres as Ibuprofen Carriers: Optimization via Full Factorial Design

Preparation and Process Optimization of Ibuprofen-Loaded PCEC Microspheres.Azouz, L'Hachemi, et al. Materials Science and Engineering: C 58 (2016): 412-419.

PCL-PEG-PCL triblock copolymer (PCEC) microspheres serve as biodegradable carriers for the anti‑inflammatory drug ibuprofen (IBF). The encapsulation efficiency (EE) was optimized using a 24 full factorial design to identify key process parameters.

Synthesis and Preparation: PCEC (Mn≈10 kDa) was synthesized by ring‑opening polymerization of ε‑caprolactone using PEG6000 as macro‑initiator and Sn(Oct)2 as catalyst. IBF‑loaded microspheres were prepared by an oil‑in‑water emulsion solvent evaporation method. Four factors were varied: shaking speed (200-1000 rpm), contact time (0.5-2.5 h), PVA concentration (0.1-2.5 %), and IBF concentration (2.5-35 % w/w relative to PCEC). Sixteen formulations (each in duplicate) were evaluated.

Performance Evaluation: ANOVA showed that IBF concentration had the most significant positive effect on EE (p < 0.0001). Higher shaking speed reduced EE, while PVA concentration showed an interactive effect with IBF content. The optimal conditions were: 200 rpm, 0.5 h, 0.1 % PVA, and 35 % IBF, giving a predicted EE of 88.86 ± 6.65 %. Experimental validation yielded 88.86 ± 3.77 %, confirming the model (R2 = 0.93). SEM revealed spherical microspheres with diameters of 90-236 μm.

Conclusion: PCL-PEG-PCL microspheres enable high encapsulation of ibuprofen under optimized low‑shear, low‑PVA, high‑drug‑loading conditions. The factorial design approach efficiently identifies critical parameters for reproducible drug delivery systems.

Please kindly note that our products are for research use only.

Online Inquiry